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Abstract. This retrospective and descriptive study was a report on the clinical situation of tuberculosis in
diabetic patients, with 1,651 patients recruited. The mean age of TBDM patients was significantly higher than
that of non-diabetic patients (p<0.05). Moreover, TBDM patients had a higher ratio of male to female than the
other group. The significant proportion of TB appeared to increase steadily with age in diabetic patients
compared to non-diabetic ones (p<0.05). However, they showed similarities in terms of sex, race, marital
status, present address, and occupation. A higher percentage of pulmonary tuberculosis (91.4%) was shown in
the TBDM group. We found that both groups had no differences in the radiological findings, with opacity or
cavity of the upper lobe involvement being 89% and 91% in TBDM and non-diabetic groups, respectively.
TBDM patients were shown to have more treatment success (33.3%), particularly the pulmonary type of
tuberculosis in the longer duration (≥ 9 months). Further findings demonstrated that a lower proportion of the
TBDM group defaulted in their treatment (19.8%) and experienced resistance to anti-tubercular therapy (1.4%)
compared to non-diabetics.
MATERIALS AND METHODS
Patients
There were 1,651 non HIV-infected patients
registered for tuberculosis treatment from January 2001
to December 2002 at the National Tuberculosis Center
(NTBC), Kuala Lumpur, Malaysia. This center is a
tertiary national reference center for respiratory
diseases situated in Kuala Lumpur, Malaysia. Any
person with a respiratory problem can attend this center
without a physician referral and majority of notified
TB cases in Kuala Lumpuur territory each year are
treated there. Data were retrospectively reviewed from
each patient’s medical record. The following
information was listed in the standardized data
collection sheet: socio-demographic profiles, clinical
presentation and investigation results, treatment,
medications and duration, patient compliance with
therapy, and outcome of therapy response. A total of
241 tuberculosis patients with diabetes (TBDM group)
were included. Diabetes mellitus was confirmed by at
least two-serum fasting glucose levels over 140 mg/
dl. An additional group of 1,410 patients with only
tuberculosis (TB group) were included and used as
control. In the population studied, neither the TBDM
nor the TB patients had clinical suspicion of human
immunodeficiency virus (HIV) or acquired immune-
deficiency syndrome (AIDS);  HIV status was tested
by various serological tests (ELISA (I,II), CLIA, or LA).
Definitions
Disease categories. The following definitions were
recommended by the World Health Organization
(2003):
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INTRODUCTION
Tuberculosis continues to be a major threat to the
health of the world, with an estimated 8-10 million
new cases and 3 million deaths annually (Kochi, 2001).
The global resurgence of TB has been accompanied
by an increased frequency of multi-drug resistant
Mycobacterium tuberculosis (MDR/TB) (Frieden et al,
1993; Pablos-Mendez et al, 1998). In Malaysia, it has
been reported that tuberculosis is among the top 5
communicable diseases, and the trend of tuberculosis
notification rates has been constantly increasing from
60/100,000 population in the year 1991 to 66/100,000
in the end of year 2001 (Ministry of Health Malaysia,
2003). Every year there has been an increase of 670,000
Malaysian people afflicted with diabetes mellitus, from
1.4 million in 1998 to 1.8 million in 2002 (Ministry of
Health Malaysia, 2002). Tuberculosis continues to be
a disease of great impact in Malaysia but there is no
data known on TB in diabetic patients. We therefore
conducted this study in order to compare epidemiology
and clinical impacts of tuberculosis between diabetic
(TBDM group) and non-diabetic (TB group). These
findings provided significant evidence and contributed
to a better understanding and proper management in
the course of tuberculosis among diabetic patients.
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Case of tuberculosis: a patient in whom tuberculosis
has been bacteriologically confirmed, or who has been
diagnosed by a clinician.
Pulmonary tuberculosis, sputum smear positive
(PTB+): (1) two or more initial sputum smear
examinations positive for Acid-Fast Bacilli (AFB) or
(2) one sputum smear examination positive for AFB
plus radiological abnormalities consistent with active
pulmonary tuberculosis as determined by a clinician,
or (3) one sputum smear positive for AFB plus sputum
culture positive for M. tuberculosis.
Pulmonary tuberculosis, sputum smear negative
(PTB-): a case of pulmonary tuberculosis which does
not meet the above definitions for smear positive TB,
in keeping with good clinical and public health
practices, diagnostic criteria should include: at least
three sputum specimens negative for AFB;
radiographic abnormalities consistent with active
pulmonary tuberculosis; no response to a course of
broad spectrum antibiotics; and a decision by a
clinician to treat with a full course of anti-tuberculosis
chemotherapy.
Extra-pulmonary tuberculosis
Tuberculosis of organs other than the lungs: eg,
pleura, lymph nodes, abdomen, genitourinary tract,
skin, joints and bones, meninges, etc. Disease should
be based on one culture positive specimen, or
histological or strong clinical evidence consistent with
active extra-pulmonary tuberculosis, followed by a
decision by a clinician to treat with a full course of
anti-tuberculosis chemotherapy.
Categories of patients for registration on diagnosis
New: a patient who has never had treatment for TB or
has taken anti-tuberculosis drugs for less than one
month.
Relapse: a patient previously treated for TB who has
been declared cured or treatment completed, and is
diagnosed with bacteriologically positive (smear or
culture) tuberculosis.
Failure: a patient who, while on treatment, is sputum
smear positive at 5 months or later during the course
of treatment.
Return after default: a patient who returns to
treatment with positive bacteriology, following
interruption of treatment for two months or more.
Transfer in: a patient who has been transferred from
another tuberculosis registry to continue treatment.
Treatment outcome
Cure: a patient who is sputum smear negative in the
last month of treatment and on at least one previous
occasion.
Treatment completed: a patient who has completed
treatment but who does not meet the criteria to be
classified as cured or failure.
Treatment failure: a patient who is sputum smear
positive at five months or later during treatment.
Died: a patient who dies for any reason during the
course of treatment.
Defaulter: a patient whose treatment was interrupted
for 2 consecutive months or more.
Transfer out: a patient who has been transferred to
another recording and reporting unit and for whom the
treatment outcome is not known.
Treatment success: the sum of patients cured and
those who completed treatment.
Statistical analysis
The data were analyzed by using the statistical
software, SPSS version 10. (SPSS Inc, Chicago, Ill,
USA). The data with quantitative variables were
expressed by median and range while the qualitative
variables were estimated by frequency and percentage.
Statistical analysis was estimated using either chi-
square test or Student’s t-test as appropriate. A p-value
of <0.05 was regarded as statistically significant.
RESULTS
Table 1 demonstrates the socio-demographic
characteristics of the study subjects at the time of
diagnosis. Patients in the TBDM group were significant
older (51.5±12.02 years, range 18-88) than in the TB
group (37.5±15.4 years, range 14-95) and had a higher
male: female ratio (2.2:1 vs 1.9:1). Age-group wise,
the significant proportion of TB appeared to increase
steadily with age in diabetic patients compared to non-
diabetic ones.  However, they showed similarities in
term of sex, race, marital status, present address, and
occupation. Among the determining factors, a lower
proportion of patients in TBDM group had
consumption of alcohol (0.5%), intravenous drug use
(3.6%), BCG vaccination (44.1%) and positive
tuberculin skin tests (32.4%). However, we found that
TBDM patients showed similar findings in history of
previous tuberculosis (6.8%) as well as contact with
TB patients (18.5%) as compared to non-diabetics.
For disease location in TBDM patients, the lung
was the most common location (91.4%) that occurred
in the TBDM group. The chest radiograph reports of
230 cases in the study group and 1,226 cases in the
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Table 1
The socio-demographic characteristics of 1, 651 patients attended at National Tuberculosis Center (NTBC) from
January 2001 to December 2002.
Variables TB group (1,410) TB DM group (241)
No. (%) No. (%)
Range of age 14-95 years 18-88 years
Mean ± SD a 37.5±15.4 years 51.5±12.02 years
Sex ratio (M:F) 1.9:1 2.2:1
Age group a
≤24 308 (22) 2 (0.8)
25-34 423 (30) 15 (6.2)
35-44 269 (19.1) 43 (17.8)
45-54 192 (13.6) 91 (38)
≥55 218 (15.5) 90 (37.3)
Sex
Male 917 (65) 167 (69.3)
Female 493 (35) 74 (30.7)
Racea
Malay 697 (49.4) 106 (44)
Chinese 318 (22.5) 73 (30.3)
Indian 149 (10.6) 42 (17.4)
1Other 246 (17.4) 20 (8.3)
Marital status a
Single 633 (45) 23 (9.5)
Married 777 (56) 218 (90.5)
Address
Kuala Lumpur 783 (55.5) 136 (56.4)
Outsider 627 (45.5) 105 (43.6)
Occupationa
Laborer 345 (24.5) 38 (15.7)
Non-laborer 392 (27.8) 51 (21.2)
Unemployed 673 (47.7) 152 (63.1)
Determining factors
Smoking
Yes 406 (29) 75 (31.1)
No 1,004 (71) 166 (69.9)
Drinking alcohol
Yes 10 (0.7) 2 (0.8)
No 1,400 (99.3) 239 (99.2)
Smoking and drinking alcohol
Yes 72 (5.1) 9 (3.7)
No 1,338 (94.9) 232 (96.3)
Intravenous drug user a
Yes 58 (4.1) 3 (1.3)
No 1,352 (95.9) 238 (98.7)
Case category
New case 1,307 (93) 226 (94)
History of previous tuberculosis
Relapse 67 (5) 12 (5)
Return after default 36 (2.5) 3 (1.3)
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Table 1 (Continued)
Variables TB group (1,410) TB DM group (241)
No. (%) No. (%)
History of contact with tuberculosis patients
Yes 273 (19.4) 46 (19.1)
No 1,137 (80.6) 195 (80.9)
BCG vaccination a
Yes 735 (52.1) 104 (43.2)
No 347 (24.6) 77 (32)
No information 328 (23.3) 60 (25)
Tuberculin skin test ( ≥ 10 mm)
Yes 521 (37) 79 (33)
No 254 (18) 48 (20)
No information 635 (45) 114 (47.3)
1Other: foreigners who were classified as persons with foreign nationality and persons with first and/or family names that were
clearly not Malaysian.
a
 p< 0.05 for differences between TBDM and TB groups by 2 samples t-test orχ2 test
 SD = standard deviation
control group were thoroughly reviewed. However,
both groups had similar findings, with opacities or
cavities and/or upper lobe involvement as the
predominant features. In the diabetics, there were 164
cases with opacities or cavitary disease; 146 (89%)
cases involved the upper lobe. In the control subjects,
there were 895 cases with opacities or cavitary disease,
and 810 (91%) cases involved the upper lobe. In extra-
pulmonary tuberculosis, osteoarticular disease was the
most common form found in diabetics, whereas, lymph
node was the predominant site in non-diabetic patients
as presented in Table 2.
This study further revealed the role of treatment
and outcome of these patients. Interestingly, we found
the treatment success and cure at ≥ 6 months in PTB
(38.4%) and at ≥ 9 months in EPT (4.6%) were more
common in the TB patients, whereas, the TBDM group
showed a higher rate of treatment success and cure
(33.3%), particularly pulmonary tuberculosis in the
longer duration (≥ 9 months). A lower proportion
(19.8%) of the TBDM group defaulted in their
treatment and experienced less MDR-TB (1.4%)
compared to non-diabetics as demonstrated in
Table 3.
DISCUSSION
We comparatively looked at socio-demographic
factors that determined the differences between these
two groups. This study clearly showed that the greater
the age, the more TB was found in diabetic patients
(Liu, 1989; Yamagishi et al, 1996; Tamura et al, 2001).
This coincides with the fact that compromised hosts
have increased susceptibility due to aging, advances
of medical technology or changes in the dietary life
and social life. Concomitantly, the proportion of
compromised hosts in the patients with tuberculosis
has also increased (Yamagishi, 2001), particularly
diabetes mellitus as one of the most frequent metabolic
distortions (Mugasi et al, 1990; Morris et al, 1992;
Schubert and Heesemann, 1995; Lin et al, 1998;
Chukanova et al, 2000). Moreover, we found that male
gender predominated in both groups; however, a
slightly higher proportion of tuberculosis was noted
in diabetic patients. Our finding is supported by a
previous reported study (Mboussa et al, 2003). The
possible explanations that predisposed diabetics to a
higher transmission rate of M. tuberculosis have been
documented by various studies (Bener, 1990; Liaw et
al, 1995; Diwan and Thorson, 1999). On the other
hand, female patients in both groups seemed to have a
much lower proportion of tuberculosis compared to
their counterpart (Chan-Yeung et al, 2002; Pérez-
Guzmán et al, 2003). Malaysia is considered a
developing country and regarded as having an
intermediate level of tuberculosis burden. Therefore,
we agree to the certain extent that the possibility of
under-diagnosis and under-notification, with
consideration of socio-economic and cultural
conditions, might play a role at least in non-diabetic
patients – a finding consistent with other studies
(Connolly and Nunn, 1996; Borgdorff et al, 2000). In
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Table 2
Disease location of TBDM patients in this study.
Disease location TB patients (1,410) TBDM patients (241)
No. (%) No. (%)
Tuberculosis (1,333)
   Lung 1,115 (79.1) 218 (90.5)
PTB and disseminated forms (123) 111 (8) 12 (5)
Lung +one site of  involvement
Lung + lymph node 47 (3.3) 2 (0.8)
Lung + pleura 22 (1.6) 2 (0.8)
Lung + bone (spine, hip, knee and ankle) 10 (0.7) 1 (0.4)
Lung + abdomen 7 (0.5) 2 (0.8)
Lung + larynx 4 (0.3) 1 (0.4)
Lung + bronchus 3 (0.2) 1 (0.4)
Lung + genitourinary tract 3 (0.2) 2 (0.8)
Lung + brain 2 (0.1) -
Lung + skin 1 (0.07) -
Lung + nasopharynx 1 (0.07) -
Lung + eye - 1 (0.4)
Lung + heart 1 (0.07) -
Lung + epiglottis 1 (0.07) -
Lung + ≥ 2 sites of involvement 9 (0.6)  -
Extrapulmonary site (195) 184 (13) 11 (4.6)
Lymph node 83 (6) 1 (0.4)
Miliary/disseminated 37 (2.6) 1 (0.4)
Pleura 22 (1.6) 3 (1.3)
Bone and joint 20 (1.4) 4 (1.7)
Abdomen 6 (0.4) -
Genitourinary tract 6 (0.4) 2 (0.8)
Skin 4 (0.3) -
Others (eye, heart, muscle, and breast) 8 (0.6) -
this context, the prevalence of tuberculosis in diabetic
patients is still high;  in addition, diabetes remains a
significant risk factor and its complications affect the
epidemiological trends of tuberculosis in this part of
the world.
From this study, pulmonary tuberculosis was
considered the most common form found in diabetic
patients and it showed a much higher proportion than
non-diabetic ones. The former observation is supported
by those reported in previous studies (Yamagishi et al,
1996; Nakamoto and Saito, 1998; Borgdorff et al,
2000); however, the latter is contrary to one study
(Pérez-Guzmán et al, 2003). This indicates that the
presence of diabetes mellitus continues to play an
important role in the development of pulmonary
tuberculosis (Yamagishi et al, 2000). Moreover, the
relative risk of developing PTB in non-insulin
dependent diabetes mellitus (NIDDM) is 5 to 7 times
higher and in insulin dependent diabetes mellitus
(IDDM), the risk is 26 times highher than the general
population of the general population (Kim et al 1995;
Feleke et al, 1999). We examined the radiological
appearance of tuberculosis in diabetic patients, which
showed similarity with the control cases; both had
predominantly upper lobe involvement. This finding
is supported by those reported in previous studies (al-
Wabel et al, 1997; Bashar et al, 2001) but contrary to
others (Marais, 1980; Morris et al, 1992; Bacakoglu
et al, 2001). Nevertheless, we support that all patients
with diabetes should undergo routine chest X ray
examination at diagnosis and whenever they develop
prolonged cough, fever, or unexplained ill health
(Ismail, 2004). In addition, PTB should be suspected
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Table 3
The anti-tubercular therapy and outcome of TBDM patients compared to TB patients.
Duration TB group (1,410) TBDM group (241) Total
PTB a EPT b PTB EPT
No (%) No (%) No (%) No (%)
At least 6 months
≥ 6 months 540 (38.3) 35 (2.5) 64 (26.5) 1 (0.4) 640
≥ 9 months 231 (16.4) 65 (4.6) 78 (32.4) 2 (0.8) 376
≥ 12 months 87 (6.2) 35 (2.5) 34 (14.1) 4 (1.7) 160
Total 858 (61) 135 (9.6) 176 (73) 7 (2.9) 1,176
Less than 6 months
Continuing 16 (1.1) - 2 (0.8) - 18
Transfer out 71 (5) 9 (0.6) 10 (4.2) - 90
Defaulted 281 (20) 40 (3) 42 (17.4) 4 (1.7) 367
Total 368 (26) 49 (3.4) 54 (22.4) 4 (1.7) 475
aPulmonary tuberculosis and disseminated forms; b Extrapulmonary tuberculosis
Drug susceptibility testing in the TB group: fully sensitive 1,404 (99.6%); resistance to 1 drug 1(0.07%) and multi-drugs resistance
4 (0.3%)
Drug susceptibility testing in the TBDM group: fully sensitive 239 (98.6%); multi-drugs resistance 2 (0.8%)
in diabetics even if the radiological features are
atypical, particularly with lower lung field involvement
(Perez-Guzman et al, 2001). In extra-pulmonary
tuberculosis, osteoarticular disease was the most
common form found in diabetics, whereas lymph node
disease was the predominant site in non-diabetic
patients. Extra-pulmonary tuberculosis was not nearly
as common as pulmonary TB, as revealed in this study.
One study found that a case may be made for early
empirical therapy to cover this organism if there is
sufficient clinical suspicion based on the presenting
signs and symptoms as well as the pattern of organ
involvement (Cunha, 1998).
Our data also showed the overall cure or treatment
completion rates of tuberculosis at 6, 9 and 12 months
were 76% in TBDM and 71% in TB patients.
Interestingly, a higher percentage of TBDM patients
occurred although treatment was usually more
prolonged, particularly for those with pulmonary
tuberculosis as compared to TB patients. In fact, PTB
is not only the primary source of infection but also its
longer treatment provides a better prognosis among
immunocompromized patients. Chemoprophylaxis is
considered necessary to prevent the development of
tuberculosis in diabetics. Moreover, it should be given
only when healing of tuberculosis has been found
despite the history of treatment for tuberculosis being
absent (Yamagishi, 2001). A higher percentage of non-
diabetic patients defaulted in treatment as well. The
possible explanation is either they were unemployed
or had MDR-TB; however, such trends occurred in
both groups and therefore deserve further investigation
before any conclusion can be made. From this study,
we found only 2 (0.8%) TBDM patients developed
resistance to anti-tubercular agents; however, once
patients had a confirmed diagnosis of MDR-TB, they
were more likely to be enrolled in DOT programs that
closely monitor therapy. This observation showed a
lesser impact compared to one previous study, which
showed a significant association between diabetes and
MDR-TB (Bashar et al, 2001). There are some
hypotheses to explain the possible factors contributing
to MDR-TB, such as non-compliance, incomplete
treatment, homelessness, and infection with the HIV
virus (Brundney, 1991; Frieden et al, 1993; Concato
and Rom, 1994). Hence, we suggest that drug
susceptibility should be strictly screened in all newly
diagnosed TB patients complicated with diabetes
mellitus. Moreover, if resistance to isoniazid and
rifampin is detected, an anti-tuberculosis regimen with
at least two new drugs, including an injectable drug
tailored to the resistance pattern, is recommended
(Harkin and Harris, 1996). No relapse cases were found
among TBDM patients; nevertheless, one study
showed that recurrences were found only in patients
with co-existent diabetes mellitus and tuberculosis
compared to other conditions (Mos-Antkowiak, 1991).
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This study further showed a poor prognosis once
relapse takes place. Therefore, plasma glucose control
should be strictly monitored (Kado et al, 1992) and an
initial intensive phase of an anti-tubercular regimen
(four-drug combination) is the preferred treatment for
the patients with DM (Kameda et al, 1990).
In conclusion, tuberculosis had a significant impact
and predominated in male patients coexisting with
diabetes mellitus. Pulmonary tuberculosis was the most
common disease location and chest X-ray findings
were an important tool in its diagnosis. Moreover, a
longer period of anti-tubercular treatment meant a
better prognosis among these patients. A small number
of MDR-TB patients were found; furthermore, no
relapses or deaths were discovered in this study.
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